Suchergebnisse
Filter
8 Ergebnisse
Sortierung:
A Game Theory Approach for Evaluating Terrorist Threats and Deploying Response Agents in Urban Environments
In: Journal of homeland security and emergency management, Band 6, Heft 1
ISSN: 1547-7355
A Game Theoretic Framework for Multi-agent Deployment in Intrusion Detection Systems
In: Annals of Information Systems; Security Informatics, S. 117-133
The evaluation analysis on the airborne dust regional pollution of the anchor drilling operation in the tunnel
In: Environmental science and pollution research: ESPR, Band 30, Heft 34, S. 82906-82926
ISSN: 1614-7499
A Game Theory Approach for Assessment of Risk and Deployment of Police Patrols in Response to Criminal Activity in San Francisco
In: Risk analysis: an international journal, Band 40, Heft 3, S. 534-549
ISSN: 1539-6924
AbstractAn efficient police patrol schedule must ensure the allocation of an appropriate number of officers sufficient to respond to the danger of criminal incidents, particularly in an urban environment, even when the available number of personnel is limited. This study proposes a framework that incorporates two game theory models designed for the allocation of police officers to patrol shifts. In the first step, the interactions of three factors between the criminal and the operation captain are modeled as a zero‐sum, noncooperative game, after which a mixed strategy Nash equilibrium method is used to derive the risk value for each district to be patrolled. In the second step, the risk values are used to compute the Shapley value for all 10 districts, for three different threat levels. A fair allocation of police personnel based on the Shapley value is made with a minimum set of personnel deployment costs. The efficacy of the proposed method is verified using openly available data from the San Francisco City Police detailing incidents from the year 2016. The experimental results show that police planners can use this framework to quantitatively evaluate the criminal threat in each district when deciding upon the deployment of patrol officers for three shifts per day.
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors
In: Journal of the International AIDS Society, Band 13, Heft 1, S. 51-51
ISSN: 1758-2652
BackgroundThis retrospective survey describes types of cancers diagnosed in HIV‐infected subjects in Asia, and assesses risk factors for cancer in HIV‐infected subjects using contemporaneous HIV‐infected controls without cancer.MethodsTREAT Asia HIV Observational Database (TAHOD) sites retrospectively reviewed clinic medical records to determine cancer diagnoses since 2000. For each diagnosis, the following data were recorded: date, type, stage, method of diagnosis, demographic data, medical history, and HIV‐related information. For risk factor analyses, two HIV‐infected control subjects without cancer diagnoses were also selected. Cancers were grouped as AIDS‐defining cancers (ADCs), and non‐ADCs. Non‐ADCs were further categorized as being infection related (NADC‐IR) and unrelated (NADC‐IUR).ResultsA total of 617 patients were included in this study: 215 cancer cases and 402 controls from 13 sites. The majority of cancer cases were male (71%). The mean age (SD) for cases was 39 (10.6), 46 (11.5) and 44 (13.7) for ADCs, NADC‐IURs and NADCs‐IR, respectively. The majority (66%) of cancers were ADCs (16% Kaposi sarcoma, 40% non‐Hodgkin's lymphoma, and 9% cervical cancer). The most common NADCs were lung (6%), breast (5%) and hepatocellular carcinoma and Hodgkin's lymphoma (2% each). There were also three (1.4%) cases of leiomyosarcoma reported in this study. In multivariate analyses, individuals with CD4 counts above 200 cells/mm3 were approximately 80% less likely to be diagnosed with an ADC (p < 0.001). Older age (OR: 1.39, p = 0.001) and currently not receiving antiretroviral treatment (OR: 0.29, p = 0.006) were independent predictors of NADCs overall, and similarly for NADCs‐IUR. Lower CD4 cell count and higher CDC stage (p = 0.041) were the only independent predictors of NADCs‐IR.ConclusionsThe spectrum of cancer diagnoses in the Asia region currently does not appear dissimilar to that observed in non‐Asian HIV populations. One interesting finding was the cases of leiomyosarcoma, a smooth‐muscle tumour, usually seen in children and young adults with AIDS, yet overall quite rare. Further detailed studies are required to better describe the range of cancers in this region, and to help guide the development of screening programmes.
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database
In: Journal of the International AIDS Society, Band 15, Heft 1, S. 1-1
ISSN: 1758-2652
BackgroundPneumocystis jiroveci pneumonia (PCP) prophylaxis is recommended for patients with CD4 counts of less than 200 cells/mm3. This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality.MethodsTAHOD patients with prospective follow up had data extracted for prophylaxis using co‐trimoxazole, dapsone or pentamidine. The proportion of patients on prophylaxis was calculated for each calendar year since 2003 among patients with CD4 counts of less than 200 cells/mm3. The effect of prophylaxis on PCP and survival were assessed using random‐effect Poisson regression models.ResultsThere were a total of 4050 patients on prospective follow up, and 90% of them were receiving combination antiretroviral therapy. Of those with CD4 counts of less than 200 cells/mm3, 58% to 72% in any given year received PCP prophylaxis, predominantly co‐trimoxazole. During follow up, 62 patients developed PCP (0.5 per 100 person‐years) and 169 died from all causes (1.36/100 person‐years). After stratifying by site and adjusting for age, CD4 count, CDC stage and antiretroviral treatment, those without prophylaxis had no higher risk of PCP, but had a significantly higher risk of death (incident rate ratio 10.8, p < 0.001). PCP prophylaxis had greatest absolute benefit in patients with CD4 counts of less than 50 cells/mm3, lowering mortality rates from 33.5 to 6.3 per 100 person‐years.ConclusionsApproximately two‐thirds of TAHOD patients with CD4 counts of less than 200 cells/mm3 received PCP prophylaxis. Patients without prophylaxis had significantly higher mortality, even in the era of combination ART. Although PCP may be under‐diagnosed, these data suggest that prophylaxis is associated with important survival benefits.